Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

NCT06904859 is registered in ClinicalTrials.gov with Shenzhen University General Hospital as lead sponsor.

NCT NCT06904859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06904859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia
Lead sponsor
Shenzhen University General Hospital
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2019
Completion date
December 30, 2020
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml)